Alpha DNA Investment Management’s Applied Materials AMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-5,440
Closed -$885K 18
2024
Q4
$885K Sell
5,440
-3,837
-41% -$695K 0.34% 59
2024
Q3
$1.87M Buy
9,277
+4,397
+90% +$902K 0.7% 31
2024
Q2
$1.15M Sell
4,880
-3,220
-40% -$691K 0.45% 37
2024
Q1
$1.67M Sell
8,100
-808
-9% -$148K 0.62% 36
2023
Q4
$1.44M Buy
8,908
+783
+10% +$115K 0.56% 35
2023
Q3
$1.12M Sell
8,125
-1,168
-13% -$167K 0.46% 42
2023
Q2
$1.34M Buy
+9,293
New +$1.16M 0.45% 37
2023
Q1
Sell
-14,677
Closed -$1.43M 150
2022
Q4
$1.43M Buy
+14,677
New +$1.41M 0.51% 33
2021
Q4
Sell
-12,975
Closed -$1.67M 102
2021
Q3
$1.67M Buy
12,975
+789
+6% +$107K 1.14% 15
2021
Q2
$1.74M Buy
12,186
+4,225
+53% +$567K 1.18% 15
2021
Q1
$1.06M Sell
7,961
-4,874
-38% -$538K 1.22% 6
2020
Q4
$1.11M Buy
+12,835
New +$949K 1.18% 6

Other funds holding AMAT

Alpha DNA Investment Management's AMAT Position: Q1 2025 in Review

Alpha DNA Investment Management sold out of Applied Materials (AMAT) in Q1 2025, closing a stake of 5,440 shares — an estimated $885K sold.

Alpha DNA Investment Management first reported a position in AMAT in Q4 2020 and held it in 12 quarters. The position peaked at $1.87M in Q3 2024. 2,157 funds tracked by Wall St. Rank hold AMAT as of Q1 2025.

  • Alpha DNA Investment Management reported no remaining Applied Materials position as of Q1 2025 after selling out during the quarter.
  • Alpha DNA Investment Management sold 5,440 Applied Materials shares in Q1 2025, an estimated $885K.
  • Alpha DNA Investment Management first reported a position in Applied Materials in Q4 2020 and held it in 12 quarters.
  • Alpha DNA Investment Management's Applied Materials position peaked at $1.87M in Q3 2024.
  • 2,157 funds tracked by Wall St. Rank held Applied Materials as of Q1 2025.

Based on Alpha DNA Investment Management's 13F filing for Q1 2025, filed 19 May 2025.